Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)

• Company Description    Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn. Number of Employees: 24,900

• Price / Volume Information    Yesterday's Closing Price: $13.08 Daily Weekly Monthly 20 Day Moving Average: 273,954 shares Shares Outstanding: 143.11 (millions) Market Capitalization: $1,871.83 (millions) Beta: 0.30 52 Week High: $20.72 52 Week Low: $10.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.72% 2.88% 12 Week 0.93% -8.32% Year To Date -23.42% -30.63%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 340 SEVEN SPRINGS WAY SUITE 100 - BRENTWOOD,TN 37027 USA ph: 615-296-3000 fax: - investor.relations@ardenthealth.com http://www.ardenthealth.com

• General Corporate Information    Officers Martin J. Bonick - President and Chief Executive Officer; Director Alfred Lumsdaine - Chief Financial Officer David Byers - Senior Vice President; Chief Accounting Officer Mark Sotir - Director Peter Bulgarelli - Director Peer Information Ardent Health, Inc. (CHCR) Ardent Health, Inc. (ESRX) Ardent Health, Inc. (MYDP) Ardent Health, Inc. (COR) Ardent Health, Inc. (GBCS) Ardent Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 03980N107 SIC: 8062 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/05/25 Share - Related Items Shares Outstanding: 143.11 Most Recent Split Date: (:1) Beta: 0.30 Market Capitalization: $1,871.83 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.42 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.82 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 1.24% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/25

• Fundamental Ratios P/E Current FY Estimate: 7.17 Trailing 12 Months: 7.23 PEG Ratio: 5.78 Price Ratios Price/Book: 1.14 Price/Cash Flow: 5.16 Price / Sales: 0.30 EPS Growth vs. Year Ago Period: 48.57% vs. Previous Quarter: 79.31% Sales Growth vs. Year Ago Period: 11.85% vs. Previous Quarter: 9.89% ROE 06/30/25 - 16.66 03/31/25 - 16.07 12/31/24 - 22.70 ROA 06/30/25 - 5.18 03/31/25 - 4.69 12/31/24 - 6.42 Current Ratio 06/30/25 - 2.13 03/31/25 - 2.12 12/31/24 - 1.94 Quick Ratio 06/30/25 - 2.00 03/31/25 - 1.98 12/31/24 - 1.82 Operating Margin 06/30/25 - 4.11 03/31/25 - 3.75 12/31/24 - 3.87 Net Margin 06/30/25 - 4.11 03/31/25 - 3.73 12/31/24 - 3.53 Pre-Tax Margin 06/30/25 - 6.78 03/31/25 - 6.32 12/31/24 - 6.09 Book Value 06/30/25 - 11.52 03/31/25 - 10.96 12/31/24 - 10.66 Inventory Turnover 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Equity 06/30/25 - 0.66 03/31/25 - 0.70 12/31/24 - 0.71 Debt-to-Capital 06/30/25 - 39.78 03/31/25 - 41.07 12/31/24 - 41.68

Powered by Zacks Investment Research ©